3826 J . Org. Chem., Vol. 66, No. 11, 2001
Parrish and Buchwald
washed with a saturated aqueous bicarbonate solution (3 ×
50 mL), dried over sodium sulfate, and concentrated in vacuo
to provide analytically pure product.
N-Meth yl-N-(4-ter t-bu tylp h en yl)a n ilin e (Table 1, entries
1-2).5 Entry 1: the reaction was performed using 1-tert-butyl-
4-iodobenzene (135 µL), N-methylaniline (105 µL), and THF
in place of toluene at 65 °C to provide the product as a tan oil
(174 mg, 97%). Entry 2: the general procedure using 1-bromo-
4-tert-butylbenzene (130 µL) and N-methylaniline (105 µL)
afforded 172 mg (96%) of the title product.
N-Meth yl-N-p h en yl-p-tolu id in e (Table 1, entry 12).30 The
reaction was performed using 4-chlorotoluene (89 µL), N-
methylaniline (105 µL), and THF in place of toluene at 65 °C
to provide the product as a tan oil (131 mg, 89%).
N-(4-Meth ylp h en yl)m or p h olin e (Table 1, entry 13).30 The
general procedure using 4-chlorotoluene (89 µL) and morpho-
line (85 µL) afforded the title compound as a yellow solid (122
mg, 92%).
Gen er a l P r oced u r e for Su zu k i Rea ction s. THF (1.00
mL) was added to an oven-dried test tube (16 × 100 mm)
sealed with a septum containing resin 3a (5.2 µmol, 0.70 mol
%) and Pd2(dba)3 (1.7 mg, 1.9 µmol, 0.25 mol %). The mixture
was stirred at 25 °C for 30-75 min. Aryl halide (0.750 mmol,
1 equiv) was added via syringe. Cesium carbonate (489 mg,
1.50 mmol, 2.00 equiv) and boronic acid (0.900 mmol, 1.20
equiv) were added simultaneously to the flask, and the system
was purged with argon. THF (0.50 mL) was added via syringe.
The flask was placed into a 65 °C oil bath, and the reaction
mixture was stirred for 17-21 h. After cooling, the mixture
was diluted with ether (5 mL), filtered through Celite, and
rinsed with ether (2 × 5 mL). The combined organic layers
were transferred to a separatory funnel and diluted with ether
(50 mL). The organic layer was washed with a 1 N aqueous
sodium hydroxide solution (3 × 50 mL), dried over sodium
sulfate, and concentrated in vacuo to provide analytically pure
product.
3-Meth oxy-4′-m eth ylbip h en yl (Table 2, entry 1). The
general procedure was modified by adding a solution of Pd2-
(dba)3 in THF (1.0 mL of a 0.75 mM solution, 0.75 µmol, 0.10
mol %) to a test tube containing ligand 3a (2.2 µmol, 0.30 mol
%). The remainder of the procedure using 3-iodoanisole (99
µL) and p-tolylboronic acid (122 mg) provided the title com-
pound as a yellow oil (138 mg, 93%). 1H NMR (300 MHz,
CDCl3) δ 7.50 (d, 2H, J ) 8.0 Hz), 7.36 (t, 1H, J ) 7.8 Hz),
7.26 (d, 2H, J ) 7.7 Hz), 7.18 (d, 1H, J ) 7.7 Hz), 7.13 (t, 1H,
J ) 2.1 Hz), 6.89 (dd, 1H, J ) 8.2, 2.5 Hz), 3.88 (s, 3H), 2.42
(s, 3H); 13C NMR (75 MHz, CDCl3) δ 159.9, 142.7, 138.2, 137.2,
129.8, 129.5, 127.1, 119.6, 112.8, 112.4, 55.4, 21.4; IR (neat,
cm-1) 3025, 2938, 1601, 1481, 1296, 1220, 1175, 1053, 1032,
867, 818, 777. Anal. Calcd for C14H14O: C, 84.80; H, 7.13.
Found: C, 84.57; H, 7.18.
N-Ben zyl-2,5-d im eth yla n ilin e (Table 1, entries 3-5).5
Entry 3: the general procedure using 2-iodo-p-xylene (105 µL)
and benzylamine (105 µL) gave 144 mg (91%) of the product
as a yellow oil. Entry 4: the general procedure was modified
by adding toluene (1.00 mL) to a test tube containing Pd(OAc)2
(3.4 mg, 15 µmol, 2.0 mol %) and ligand 3a (19 µmol, 2.5 mol
%) for the catalyst premix. The remainder of the procedure
using 2-bromo-p-xylene (105 µL) and benzylamine (105 µL) at
100 °C afforded 145 mg (92%) of the title compound. Entry 5:
the general procedure using 2-chloro-p-xylene (101 µL) and
benzylamine (105 µL) provided 151 mg (96%) of the product.
N-(3-Meth oxyp h en yl)-n -h exyla m in e (Table 1, entry 6).
The general procedure was performed using 3-iodoanisole (99
µL) and n-hexylamine (295 µL, 2.25 mmol, 3.00 equiv). The
residue was purified by flash chromatography (2% EtOAc/
hexanes) to afford the desired product as a pale yellow oil (130
mg, 84%) and the diarylation byproduct (8.2 mg, 3%). 1H NMR
(300 MHz, CDCl3) δ 7.08 (t, 1H, J ) 8.1 Hz), 6.25 (m, 2H),
6.17 (t, 1H, J ) 2.3 Hz), 3.79 (s, 3H), 3.64 (br s, 1H), 3.10 (t,
2H, J ) 6.9 Hz), 1.63 (m, 2H), 1.44-1.31 (m, 6H), 0.92 (t, 3H,
J ) 6.9 Hz); 13C NMR (75 MHz, CDCl3) δ 160.8, 150.0, 129.9,
106.0, 102.2, 98.6, 55.2, 44.1, 31.9, 29.7, 27.1, 22.9, 14.3; IR
(neat, cm-1) 3405, 2926, 2854, 1613, 1510, 1460, 1210, 1160,
1046, 826, 753. Anal. Calcd for C13H21NO: C, 75.31; H, 10.23.
Found: C, 75.59; H, 10.25.
N-(4-ter t-Bu tylp h en yl)m or p h olin e (Table 1, entry 7).5
The general procedure using 1-bromo-4-tert-butylbenzene (130
µL) and morpholine (85 µL) provided 146 mg (89%) of the title
compound as an ivory solid.
N,N-Dibu tyl-3,5-d im eth yla n ilin e (Table 1, entry 8). The
general procedure using 5-bromo-m-xylene (102 µL) and dibu-
tylamine (165 µL) gave 139 mg (79%) of the title compound as
a yellow oil. 1H NMR (300 MHz, CDCl3) δ 6.31 (s, 1H), 6.29 (s,
2H), 3.25 (t, 4H, J ) 7.6 Hz), 2.28 (s, 6H), 1.57 (m, 4H), 1.36
(m, 4H), 0.97 (t, 6H, J ) 7.3 Hz); 13C NMR (75 MHz, CDCl3)
δ 148.4, 138.7, 117.3, 109.8, 51.0, 29.8, 22.2, 20.7, 14.3; IR
(neat, cm-1) 2957, 2867, 1599, 1485, 1366, 1194, 814. Anal.
Calcd for C16H27N: C, 82.33; H, 11.68. Found: C, 82.07; H,
11.49.
4-ter t-Bu tyl-2′-m eth ylbip h en yl (Table 2, entry 2).4 The
general procedure was modified by adding a solution of Pd2-
(dba)3 in THF (1.5 mL of a 0.75 mM solution, 1.1 µmol, 0.15
mol %) to a test tube containing ligand 3a (3.4 µmol, 0.45 mol
%). The remainder of the procedure using 1-tert-butyl-4-
iodobenzene (135 µL), o-tolylboronic acid (122 mg), and no
additional THF gave the title compound as a yellow oil (164
mg, 98%).
4-ter t-Bu tylbip h en yl (Table 2, entry 3).4 The general
procedure using 1-bromo-4-tert-butylbenzene (130 µL) and
phenylboronic acid (110 mg) afforded the title compound as a
yellow solid (155 mg, 98%).
N-(4-Meth oxyp h en yl)m or p h olin e (Table 1, entry 9).30
The general procedure using 4-bromoanisole (94 µL) and
morpholine (85 µL) afforded the title compound as a tan solid
(125 mg, 86%).
2,6-Dim eth ylbip h en yl (Table 2, entry 4).4 The general
procedure using 2-bromo-m-xylene (100 µL) and phenylboronic
acid (110 mg) provided the title compound as a pale yellow oil
(124 mg, 91%).
N-(2,5-Dim eth ylp h en yl)-m -tolu id in e (Table 1, entries
10-11). Entry 10: the general procedure was modified by
adding toluene (1.00 mL) to a test tube containing Pd2(dba)3
(3.4 mg, 3.8 µmol, 0.50 mol %) and ligand 3a (9.8 µmol, 1.3
mol %). The remainder of the procedure using 2-bromo-p-
xylene (105 µL) and m-toluidine (105 µL) at 100 °C provided
the product as a tan oil (157 mg, 99%). Entry 11: the general
procedure was modified by adding toluene (1.00 mL) to a test
tube containing Pd2(dba)3 (5.2 mg, 5.6 µmol, 0.75 mol %) and
ligand 3a (14 µmol, 1.9 mol %). The remainder of the procedure
using 2-chloro-p-xylene (101 µL) and m-toluidine (105 µL) at
100 °C gave the title compound in 98% (156 mg). 1H NMR (300
MHz, CDCl3) δ 7.19-7.08 (m, 3H), 6.80-6.73 (m, 4H), 5.32
(br s, 1H), 2.33 (s, 3H), 2.30 (s, 3H), 2.23 (s, 3H); 13C NMR (75
MHz, CDCl3) δ 144.1, 141.1, 139.2, 136.5, 130.8, 129.2, 125.3,
122.8, 121.3, 119.7, 118.2, 114.6, 21.8, 21.4, 17.7; IR (neat,
cm-1) 3388, 2920, 1604, 1577, 1476, 1310, 1170, 1000, 771.
Anal. Calcd for C15H17N: C, 85.25; H, 8.13. Found: C, 85.28;
H, 8.30.
2,5-Dim eth yl-2′-m eth ylbip h en yl (Table 2, entries 5 and
8).4 Entry 5: the general procedure using 2-bromo-p-xylene
(105 µL) and o-tolylboronic acid (153 mg, 1.12 mmol, 1.50
equiv) gave the product as a yellow oil (146 mg, 99%). Entry
8: the general procedure using 2-chloro-p-xylene (101 µL),
o-tolylboronic acid (306 mg, 2.25 mmol, 3.00 equiv), Pd2(dba)3
(3.4 mg, 3.8 µmol, 0.50 mol %), and ligand 3a (9.75 µmol, 1.30
mol %) provided the title compound (146 mg, 99%).
3-(1,3-Dioxola n e)-2′-m eth oxybip h en yl (Table 2, entry
6).4 The general procedure using 2-(3-bromophenyl)-1,3-diox-
olane (115 µL), 2-methoxyphenylboronic acid (137 mg), Pd2-
(dba)3 (2.4 mg, 2.6 µmol, 0.35 mol %), and ligand 3a (7.50 µmol,
1.00 mol %) afforded the product as a viscous oil (175 mg, 91%).
3-Ca r bom eth oxy-4′-m eth ylbip h en yl (Table 2, entry 7).
The general procedure using methyl 3-chlorobenzoate (105 µL)
and p-tolylboronic acid (152 mg, 1.12 mmol, 1.50 equiv)
1
provided the product as a yellow oil (154 mg, 91%). H NMR
(30) Wolfe, J . P.; Buchwald, S. L. J . Org. Chem. 1996, 61, 1133.
(300 MHz, CDCl3) δ 8.27 (t, 1H, J ) 1.7 Hz), 8.00 (dt, 1H, J )